List view / Grid view

MabVax Therapeutics



MabVax files IND with the FDA for HuMab 5B1

2 December 2015 | By Victoria White

In preclinical research, the 5B1 antibody has demonstrated high specificity and affinity, and has shown potent cancer cell killing capacity and efficacy in animal models of pancreatic, colon and small cell lung cancers...